Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CANT1
Introduction
CANT1 is a gene that encodes soluble calcium-activated nucleotidase 1, an enzyme, in humans.[1][2]
References
References
- ↑ Failer BU, Braun N, Zimmermann H (Sep 2002). “Cloning, expression, and functional characterization of a Ca(2+)-dependent endoplasmic reticulum nucleoside diphosphatase”. J Biol Chem. 277 (40): 36978–86. doi:10.1074/jbc.M201656200. PMID 12167635.
- ↑ “Entrez Gene: CANT1 calcium activated nucleotidase 1”.
External links
External links
- Human CANT1 genome location and CANT1 gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Smith TM, Hicks-Berger CA, Kim S, Kirley TL (2002). “Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases”. Arch. Biochem. Biophys. 406 (1): 105–15. doi:10.1016/S0003-9861(02)00420-4. PMID 12234496.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Murphy DM, Ivanenkov VV, Kirley TL (2003). “Bacterial expression and characterization of a novel, soluble, calcium-binding, and calcium-activated human nucleotidase”. Biochemistry. 42 (8): 2412–21. doi:10.1021/bi026763b. PMID 12600208.
- Matsuda A, Suzuki Y, Honda G, et al. (2003). “Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways”. Oncogene. 22 (21): 3307–18. doi:10.1038/sj.onc.1206406. PMID 12761501.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Dai J, Liu J, Deng Y, et al. (2004). “Structure and protein design of a human platelet function inhibitor”. Cell. 116 (5): 649–59. doi:10.1016/S0092-8674(04)00172-2. PMID 15006348.
- Yang M, Kirley TL (2004). “Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change”. Biochemistry. 43 (28): 9185–94. doi:10.1021/bi049565o. PMID 15248776.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Otsuki T, Ota T, Nishikawa T, et al. (2007). “Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries”. DNA Res. 12 (2): 117–26. doi:10.1093/dnares/12.2.117. PMID 16303743.